NEUROTROPHIC PEPTIDE DERIVATIVES

The invention provides neurotrophic peptide derivatives represented by A6-A7 (wherein A6 and A7 are as defined in the specification) including ¢D-Ala1! HCNP. The neurotrophic peptide derivatives can regulate differentiation and maturation of neuronal cells to accelerate the acetylcholine synthesis i...

Full description

Saved in:
Bibliographic Details
Main Authors UEKI, YASUYUKI, IRIE, TSUNEMASA, IKEDA, YOSHIHARU, FUKUSHIMA, NOBUYUKI, NISHIHARA, TOSHIO, ONO, KEIICHI
Format Patent
LanguageEnglish
French
Published 13.03.1992
Edition6
Subjects
CHEMISTRY
CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION ORPROCESSING OF GOODS
GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC
GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINSTCLIMATE CHANGE
Online AccessGet full text

Cover

More Information
Summary:The invention provides neurotrophic peptide derivatives represented by A6-A7 (wherein A6 and A7 are as defined in the specification) including ¢D-Ala1! HCNP. The neurotrophic peptide derivatives can regulate differentiation and maturation of neuronal cells to accelerate the acetylcholine synthesis in the tissue of medial septum nuclei which is rich in cholinergic neurons and are thus useful for the treatment of neuro-degenerative disorders and dementia.
Bibliography:Application Number: CA19912051157